Rule 144 planned sale of 243,976 shares

A planned sale notice under Rule 144 covers 243,976 shares of Common Stock, to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Rhea-AI Filing Summary

A planned sale notice under Rule 144 covers 243,976 shares of Common Stock, to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market. The shares have an aggregate market value of 438,522.46 and are part of a total of 224,730,144 shares outstanding.

The seller acquired these shares as restricted stock vesting under a registered plan from the issuer on 01/31/2026, treated as compensation. The approximate planned sale date is 02/02/2026, and the signer represents not knowing any undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALLO shares are planned for sale in this Form 144?

The notice covers a planned sale of 243,976 shares of Common Stock. These shares were recently acquired through restricted stock vesting under a registered plan and are intended to be sold on NASDAQ through a designated broker.

What is the aggregate market value of the ALLO shares to be sold?

The aggregate market value of the 243,976 Common Stock shares covered by this notice is 438,522.46. This value reflects the total market worth of the planned sale at the time the notice information was prepared.

How were the ALLO shares in this Form 144 acquired?

The shares were acquired as restricted stock vesting under a registered plan from the issuer on 01/31/2026. The table identifies the nature of payment as compensation, indicating they were not purchased for cash in the open market.

When is the approximate sale date for the ALLO shares under Rule 144?

The notice lists an approximate date of sale of 02/02/2026. This indicates when the holder expects to begin selling the 243,976 Common Stock shares on NASDAQ through the named broker, subject to Rule 144 conditions.

How many ALLO shares are outstanding compared with this planned sale?

The filing shows 224,730,144 shares of Common Stock outstanding. The planned Rule 144 sale involves 243,976 shares, providing context for the relative size of the potential sale compared with the total outstanding share count.

Which broker will handle the ALLO Rule 144 share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is listed for executing the NASDAQ transactions for the covered shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:51 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001611024
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALLOGENE THERAPEUTICS, INC.
SEC File Number	001-38693
Address of Issuer	210 East Grand Avenue South San Francisco CALIFORNIA 94080
Phone	(650) 457-2700
Name of Person for Whose Account the Securities are To Be Sold	DAVID CHANG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	243976	438522.46	224730144	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted stock vesting under a registered plan	Issuer			243976	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Chang
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)